Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.
СтатьяConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Zhenggang, Kitayama Joji, Kim Hyung-Ho, So Jimmy Bok-Yan, Cao Hui, Chen Lin, Cheng Xiangdong, Hu Jiankun, Imano Motohiro, Ishigami Hironori, Jee Ye Seob, Kim Jong-Han, Kodera Yasuhiro, Liang Han, Liu Xiaowen, Lu Sheng, Mou Yiping, Nie Mingming, Seo Won Jun, Wang Yanong, Wu Dan, Xu Zekuan, Yamaguchi Hironori, Yan Chao, Yang Zhongyin, Yin Kai, Yonemura Yutaka, Yong Wei-Peng, Yu Jiren, Zhang Jun, Asian Gastric Cancer NIPS Treatment Collaborative Group
Аннотация
Peritoneal metastasis (PM) is a major challenge in advanced gastric cancer (GC) with poor prognosis. Normothermic intraperitoneal and systemic treatment (NIPS) has become a promising therapeutic approach. This consensus aims to provide practical recommendations for NIPS treatment for gastric cancer with peritoneal metastasis (GCPM). The GRADE standards were used to rank evidence, and the Delphi method was employed for expert voting. 30 experts from China, Japan, South Korea, and Singapore participated in the development of this consensus. 28 experts participated in the voting process, which produced 29 statements covering diagnostic approaches, patient selection criteria, treatment regimens, management of intraperitoneal port placement, and conversion surgery considerations, and post-surgical treatment strategies in NIPS therapy. Based on current evidence and expert experience, these statements aim to improve the clinical outcomes of NIPS therapy for GCPM patients.